Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
Intrinsic Value
Taisho Pharmaceutical Holdings Co. Ltd. engages in the management of its group companies which are engaged in the manufacture and sale of over-the-counter (OTC) drugs, food, and miscellaneous goods. [ Read More ]
The intrinsic value of one Taisho Pharmaceutical Holdings Co Ltd stock under the Base Case scenario is 5 057.79 JPY. Compared to the current market price of 8 570 JPY, Taisho Pharmaceutical Holdings Co Ltd is Overvalued by 41%.
Valuation Backtest
Taisho Pharmaceutical Holdings Co Ltd
Run backtest to discover the historical profit from buying and selling Taisho Pharmaceutical Holdings Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Taisho Pharmaceutical Holdings Co Ltd's business.
What risks and challenges
does Taisho Pharmaceutical Holdings Co Ltd face in the near future?
Summarize the latest earnings report
of Taisho Pharmaceutical Holdings Co Ltd.
Provide P/E
for Taisho Pharmaceutical Holdings Co Ltd and its competitors.
Balance Sheet Decomposition
Taisho Pharmaceutical Holdings Co Ltd
Current Assets | 416.8B |
Cash & Short-Term Investments | 266.4B |
Receivables | 72.6B |
Other Current Assets | 77.9B |
Non-Current Assets | 588.7B |
Long-Term Investments | 167.6B |
PP&E | 149B |
Intangibles | 247.5B |
Other Non-Current Assets | 24.5B |
Current Liabilities | 80.8B |
Accounts Payable | 16.5B |
Accrued Liabilities | 21.1B |
Other Current Liabilities | 43.3B |
Non-Current Liabilities | 92.5B |
Other Non-Current Liabilities | 92.5B |
Earnings Waterfall
Taisho Pharmaceutical Holdings Co Ltd
Revenue
|
320.4B
JPY
|
Cost of Revenue
|
-137.2B
JPY
|
Gross Profit
|
183.2B
JPY
|
Operating Expenses
|
-164.3B
JPY
|
Operating Income
|
18.9B
JPY
|
Other Expenses
|
-10.5B
JPY
|
Net Income
|
8.4B
JPY
|
Free Cash Flow Analysis
Taisho Pharmaceutical Holdings Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Taisho Pharmaceutical Holdings Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Taisho Pharmaceutical Holdings Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Taisho Pharmaceutical Holdings Co Ltd's solvency score is 88/100. The higher the solvency score, the more solvent the company is.
Score
Taisho Pharmaceutical Holdings Co Ltd's solvency score is 88/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Taisho Pharmaceutical Holdings Co Ltd
According to Wall Street analysts, the average 1-year price target for Taisho Pharmaceutical Holdings Co Ltd is 5 600 JPY .
Shareholder Return
Price
Taisho Pharmaceutical Holdings Co Ltd
Average Annual Return | -12.74% |
Standard Deviation of Annual Returns | 13.44% |
Max Drawdown | -54% |
Market Capitalization | 702.5B JPY |
Shares Outstanding | 82 094 593 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Taisho Pharmaceutical Holdings Co. Ltd. engages in the management of its group companies which are engaged in the manufacture and sale of over-the-counter (OTC) drugs, food, and miscellaneous goods. The company is headquartered in Toshima, Tokyo-To and currently employs 9,134 full-time employees. The company went IPO on 2011-10-03. The firm operates in two business segments. The Self-Medication segment is engaged in the research, development, manufacture and sale of over-the-counter drugs, quasi-drugs, foods, medical supplies, hygiene products. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of ethical drugs. The other business is engaged in the leasing and management of real estate, as well as hotel management business.
Contact
IPO
Employees
Officers
The intrinsic value of one Taisho Pharmaceutical Holdings Co Ltd stock under the Base Case scenario is 5 057.79 JPY.
Compared to the current market price of 8 570 JPY, Taisho Pharmaceutical Holdings Co Ltd is Overvalued by 41%.